pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Cardiology · news · pharmadog
← back to Cardiology
News · Cardiology
591
stories
6h
Significant stock movers of September: Viking soars, Longeveron slides
biospace
11h
Optogenetics researchers win a Nobel Prize; Roche bets on Alector brain drug
biopharma dive
13h
Could we one day vaccinate against every cancer?
stat
16h
Opinion: Energy drinks’ new college sports partnerships make them more dangerous than ever
stat
21h
Roivant, the 'inveterate drug hunters', enters commercial era with Lisraya
biospace
23h
FDA signs off on first heart valve designed to dynamically expand in children
fiercebiotech
3d
NIH rolling out streamlined website to help public find information more easily
stat
3d
This week in charts: Kodiak’s big comeback and Hengrui’s dealmaking
biopharma dive
3d
Foghorn cuts 40% of workforce
biospace
3d
Novartis wagers almost $8B on a Chinese biotech’s RNA drugs
biopharma dive
3d
STAT+: Pharmalittle: We’re reading about the 340B drug pilot program, an obesity drug disappointment, and more
stat
3d
#EASD26: Regeneron sees a future combining its obesity drug with lipid-lowering therapy
endpoints
3d
Immunotherapy startup Adecto blames ‘risk-averse funding environment’ for closing down
fiercebiotech
4d
FDA Approves First Heart Valve Designed to Grow with Children
fda press
4d
Top journal’s special issue on women’s health casts spotlight on menopause and pain
stat
4d
Mistrust in science and a juicy gene-editing lawsuit
stat
4d
As CDC redesigns annual health survey, it removes questions about disabilities
stat
5d
Superior weight loss, blood sugar control propel Lilly’s amylin-GIP/GLP-1 combo into Phase 3
biospace
5d
FDA Launches Nationwide Effort to Expand Scientific Expertise and Consumer Voices to Advisory Committees
fda press
5d
Opinion: STAT+: What to think about those mice with half-human brains
stat
5d
Roche, Zealand see phase 2 amylin weight loss peak at mid-dose, start pivotal program
fiercebiotech
5d
Biopharma needs to reward scientists' judgment
biospace
5d
Biopharma needs to reward scientists' judgment
biospace
5d
Lilly sets up next-gen obesity battle with full phase 3 retatrutide data
fiercebiotech
6d
STAT+: AstraZeneca invests $2 billion in Summit Therapeutics
stat
6d
Swedish biotech AnaCardio raises $70.9M to advance 'safer' heart failure drug
endpoints
6d
Opinion: Massive SNAP cuts could mean more children are separated from their families
stat
6d
Opinion: Child health is the national security crisis we keep ignoring
stat
7d
FDA Approves First Treatment for MCT8 Deficiency
fda press
7d
‘We’re so close to the tech companies’: Genentech CEO talks Fierce through vision for the future
fiercebiotech
← prev
page 1 of 20
next →
